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Results: Patients between ages 30 and 60 years with MetS diagnosis were included in
this study. 31 patients (41.9%) were male and 43 patients (58.9%) were female.
Patients were divided into 2 groups according to CIMT measurement: 35 patients with
CIMT 1,0 mm were at group 1 and 39 patients with CIMT<1,0 mm were at group 2.
There were difference only age and fasting blood glucose parameter among groups. In
the multi-varians analysis, age and fasting blood glucose related in CIMT values were
not statistically signiﬁcant (p>0.05). Additionally, the common effect of age and
fasting blood glucose variables on the CIMT values were not statistically signiﬁcant
(p¼0.241). The MPV level was signiﬁcantly higher in patients with CIMT 1,0 mm
than in patients with CIMT <1,0 mm (8.20.7 vs. 7.80.6 ﬂ; p¼0.01) (Figure 1).
Conclusıons: The risk of atherosclerosis could be shown with following the MPV
values in MetS patients. Therefore, our results suggest that MPV is an important
marker for early detecting the risk of atherosclerosis in patients with MetS. In our
study, we showed that this risk could be determined with a simple blood count. Risk
of atherosclerosis can be assessed by examining the values of MPV, without any
additional blood tests or radiological examination.Table 1
Group 1
CIMT 1,0 mm
(mean sd)
Group 2
CIMT<1,0 mm
(mean sd) P
Number of patients (n) 35 39
Age (years) 51.96.5 46.68.1 0.003
Gender (F/M, n) 23/12 19/20 0.16
BMI (kg/m2) 31.34.0
30 (25-42)
32.25.0
31 (26-46)
0.62
Waist circumference (cm) 102.19.7 104.210.6 0.38
HT [n(%)] 14(40.0) 15(38.4) 0.94
DM [n(%)] 15(42.9) 10(25.6) 0.08
Smoking [n(%)] 6(17.1) 9(23.0) 0.33
SBP (mmhg) 128.111.8
130 (100-160)
124.612.5
120 (110-160)
0.09
DBP (mmhg) 81.87.1
80 (60-100)
79.47.1
80 (70-100)
0.06
Fasting glucose (mg/dl) 114.424.7
109 (76-206)
106.130.3
101 (81-260)
0.02
HbA1c (%) 6.30.9 6.10.99 0.37
HDL-cholesterol (mg/dl) 44.111.2 39.512.7 0.10
LDL-cholesterol (mg/dl) 116.536.1 120.739.2 0.63
Triglyceride (mg/dl) 178.180.8 217.6108.9 0.08
Hemoglobin (g/dl) 13.31.2 13.61.4 0.23
Platelet (x109/l) 256.461.2 286.866.2 0.04
MPV (ﬂ) 8.20.7 7.80.6 0.01
Baseline characteristcs of patients (BMI: body mass index, HT: hypertension, DM: diabetes
mellitus, SBP: systolic blood pressure, DBP: diastolic blood pressure, LDL: low-density lipo-
protein, HDL: high-density lipoprotein, MPV: mean platelet volume
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Endothelin Antagonists may be a Treatment Option for Cardiac Syndrome X, or
Not ?
S¸eyda Günay, _Ibrahim Baran, Ali Aydınlar, Osman Akın Serdar, Sümeyye Güllülü,
Dilek Yes¸ilbursa, Bülent Özdemir, Aysel Aydın Kaderli, Tunay S¸entürk, Saim Sag
Uludag University Faculty of Medicine Department of Cardiology, Bursa
Atherosclerosis is a systemic disease which effects large and medium sized arteries
besides coronary arteries. Atherosclerosis and associated diseases are the leading
cause of death all over the world. It is known that endothelial dysfunction already
starts before atherosclerotic involvement of coronary arteries. To diagnose athero-
sclerosis before organ damage has occured is important. The aim of the study is to
evaluate the relationship between endothelial dysfunction and serum endothelin-1
levels, small artery elasticity, coronary artery disease severity and also to seek an
answer if endothelin-1 antagonists may be beneﬁcal for cardiac Syndrome X or not.
Patients with chest pain were evaluated with exercise stress test or myocardial
perfusion scintigraphy. Then ischemia deteceted patients underwent elective coronary
angiography. Using ELISA method serum endothelin-1 levels of all patients were
measured and a radial artery tonometer was used to measure arterial elasticity of all
patients. The patients were grouped according to coronary artery disease history,
ischemia existence and coronary angiogram results. The groups were compared with
regards to serum endothelin-1 level, small artery elasticity and Gensini scores.
In the study group, 50 patients (62,5%) were male and 30 (37,5%) were female and
the average age was 58,4 10,7 years. Twenty six (32,5%) of the patients had
coronary artery disease history. Ischemia was present in 55 (68%) patients. Critical
coronary lesions were present in 21 (38%) patients who underwent coronary angi-
ography. Median serum endothelin-1 level was 18,9 ng/L (8,5-134,9 ng/L) in patients
with ischemia and 14,8 ng/L (8,4-41,5 ng/L) in patients without ischemia. Serum
endothelin-1 level of ischemic patients was higher (p¼0.045). There wasn't a statisti-
cally signiﬁcant relationship between serum endothelin- 1 levels and coronary artey
disease history, small artery elasticity, Gensini scores.
Because of serum endothelin-1 level of patients without coronary artery disease history
but with ischemia and normal coronary angiograms was higher than non-ischemic
patients, it is assumed that endothelin-1 antagonistsmaybebeneﬁcal for cardiacSyndrome
X. To support this, there is a need for large prospective population based studies.
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The Relationship between Serum 25-hydroxyvitamin D levels and In-Stent
Restenosis in Patients with Stable Coronary Artery Disease
Alparslan Kurtul1, Mustafa Duran1, Mikail Yarlıoglues¸1, Muhammed Karadeniz1,
Gökhan Ergün1, Ertan Vurus¸kan2, Emre Akkaya2, Sani Namık Murat1
1Ankara Education and Research Hospital, Ankara, 2Gaziantep Government
Hospital, Gaziantep
Background: It has been shown that low levels of 25-hydroxyvitamin D are asso-
ciated with increased cardiovascular risk factors and events. The relationship between
serum 25-hydroxyvitamin D level and in-stent stenosis was investigated in our study.
Methods: A total of 181 patients with stable coronary artery disease and previously
implanted (>3 months) bare-metal stent were included in the study. Two groups were
formed according to angiographic results as Group 1 (50% in-stent stenosis) and
Group 2 (<50% in-stent stenosis). Serum 25-hydroxyvitamin D measurements were
performed by reverse-phase HPLC.
Results: The mean serum 25-hydroxyvitamin D level was found to be signiﬁcantly
lower in Group 1 compared to Group 2 (17.75.3 ng/ml and 20.96.7 ng/ml, p<0.01,
respectively) and length of stent was longer in Group 1 compared to Group 2
(18.75.3 mm and 17.111.2 mm, p<0.01, respectively). In multivariate logistic
regression analysis, only low level of serum 25-hydroxyvitamin D was an independent
risk factor for in-stent stenosis (p<0.01, OR¼0.915, 95% CI 0.866-0.967).
Conclusıon: Our results suggest that lower levels of 25-hydroxyvitamin D are
associated with an increased risk of in-stent stenosis.
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High Prevalence of Glucose Intolerance and Diabetes in Patients with Coronary
Artery Disease
Sinan Varol, Vedat Sansoy, Okay Abacı, Muhsin Kalyoncuoglu
Institute of Cardiology, Istanbul University, Istanbul
Purpose: Our purpose was to investigate the relationship between the prevalence of
glucose intolerance and type 2 diabetes with cardiometabolic risk factors in patients
with asymptomatic coronary artery disease.
Methods: 132 patients who had not been previously diagnosed with glucose intol-
erance or diabetes, and had coronary artery disease (CAD) were enrolled. 2 hour
standard oral glucose tolerance test (OGTT) with 75 gr. glucose was conducted.
Patients were divided into two groups as normal and with impaired glucose tolerance
(IGT) or diabetes (DM). Groups were compared according to waist circumference,
body-muscle index, creatinin clearance, risk factors of CAD, severity of CAD,
functional capacity, angina score. In patients with Fasting plasma glucose (FPG)<100
mg/dl, HOMA-IR values were investigated. For statistical analysis, t-test, Mann-
Whitney U, Kruskal Wallis or logistic regression test were used.
Result: Prevelance of IGT(%26) or DM (%4) was %30 in patients with CAD. %27 of
patients had a value of FPG <100 mg/dl before the test was conducted. Between theERS C213
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Sgroups, waist-hip ratio, creatinine levels were signiﬁcantly high; glomerular ﬁltration
rate (GFR) was low in IGT or DM group compared to the other one whose OGTT test
was normal. In these parameters, GFR predicted IGT or DM with %72 sensitivity and
%55 speciﬁty. Before the test, patients with FPG <100 mg/dl, %30 of patients had
insülin resistance.
Conclusıon: In signiﬁcant part of patients with CAD, IGT or DM was present despite
normal FPG. Conventional risk factors, severity or duration of CAD cannot predict
IGT or DM. OGTT testing for IGT or DM, independent from FPG, would contribute
to the diagnosis.PP-334
Serum Vitamin D and CRP Levels are Independently Associated with Diastolic
Dysfunction
Fatih Akın1, Burak Ayça2, Nuri Köse1, Ömer Celik3, Hüseyin Arinç4
1Department of Cardiology, Mugla Sıtkı Kocman University School of Medicine,
Mugla, 2Department of Cardiology, Bagcılar Education and Research Hospital,
Istanbul, 3Mehmet Akif Ersoy Chest and Cardiovascular Surgery Education and
Research Hospital, Istanbul, 4Department of Cardiology, Kayseri Education and
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Aım: Vitamin D deﬁciency is common and may contribute to cardiovascular diseases.
We hypothesized that serum vitamin D (25OHD) levels would be inversely associated
with inﬂammation and with diastolic dysfunction. We therefore investigated the link
between serum vitamin D levels (i) echocardiographic measures and (ii) inﬂammatory
parameters.C214 JACC VoMaterıals-Methods: The cross-sectional study included 281 patients who were
referred to coronary angiography for stable angina pectoris. Patients were recruited
between December 2010 and November 2011. Patients with established congestive
heart failure, gout, chronic kidney disease (estimated glomeruler ﬁltration rate <60
ml/min/1.73 m2), acute infection were not included. We measured serum 25OHD
levels, C-reactive protein (CRP) and ﬁbrinogen levels. A radioimmunoassay proce-
dure was used to measure 25OHD (DiaSorin, Stillwater, MN). We also performed
standardized left ventricular (LV) echocardiograms and echocardiographic data were
used for classiﬁcation of systolic and diastolic dysfunction. We analyzed the relation
between serum levels of 25OHD and inﬂammatory markers and echocardiographic
measures of left ventricular mass and diastolic dysfunction.
Results: At baseline, subjects had a mean age of 59.510 years and 43.4% were
women. Left ventricular mass index, left atrial diamater, isovolumic relaxation time,
E/E’ ratio were signiﬁcantly higher in patients with lower 25OHD levels. In ordinal
logistic regression analysis higher 25OHD was negatively associated only with left
ventricular mass index, OR¼0.965 (0.939-0.992) p¼0.015, isovolumic relaxation
time, OR¼0.962 (0.939-0,985) p¼0.001, E/E’ ratio, OR¼0.874 (0.811-0.942)
p¼0.008 and CRP, OR¼0.802 (0.668-0.962) p¼0.021.
Conclusıon: Serum levels of 25OHD are signiﬁcantly associated with LV diastolic
dysfunction and left ventricular mass index although the effect size is rather small.
Longitudinal studies in larger populations are needed to establish ﬁrmly or refute
a causal relationship between vitamin D levels and diastolic dysfunction and left
ventricular mass index.
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The prognostic Signiﬁcance of Vitronectin in Acute Myocardial Infarction
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Introductıon: Vitronectin (VN), a 459 aminoacid long glycoprotein with a mass of 75
kDa, is found in plasma, extracellular matrix and a granules of platelets. Plasma VN
levels were found to be elevated in patients with coronary artery disease (CAD), and
a positive correlation between VN levels and CAD severity has been demonstrated.
VN was also shown to be an independent predictor of adverse cardiovascular
outcomes following acute stenting in patients with acute myocardial infarction (AMI)
or stable angına.
The aim of this study was to assess prognostic signiﬁcance of serum VN levels at
admission in patients with ACS.
Method: Sixty-two patients (40 men, mean age 59.910.3 years and 22 women,
mean age 68.911.2 years), who had been admitted to coronary care unit with ﬁrst
time diagnosis of ACS (ST elevation myocardial infarction [STEMI], non-ST elevation
myocardial infarction [NSTEMI]) were consecutively included in the study.The control
group consisted of 18 stable patients in whom normal coronary arteries were docu-
mented in coronary angiography. Patients were divided into two sub-groups as STEMI
andNSTEMI and theywere followed up for sixmonths formajor adverse cardiovascular
events (MACE) consisting of cardiovascular mortality, re-infarction, hospitalization for
decompensated heart failure and life threatening arrhythmias. Blood samples were
drawn within 6 hours after onset of chest pain and serum VN, high sensitive C-reactive
protein (hs-CRP) and N-terminal probrain natriuretic peptide (NT-proBNP) levels were
measured using an enzyme immunoassay method. Also, TIMI and GRACE clinical risk
scores were calculated on admission for all ACS patients.
Results: The mean VN level in patients with MACE at six months was signiﬁcantly
higher (12.09 mg/ml +/- 20.79 mg/ml vs. 3.74 mg/ml +/- 7.48 mg/ml, p<0.001)
compared to the rest of the patient group. Patients in the upper two VN quartiles had
signiﬁcantly higher in-hospital (p¼0.026) and six months (p<0.001) MACE rates
compared to the patients in the lower two quartiles. Using ROC analysis, a cut-off VN
value of 2.16 mg/ml was able to predict MACE at six months with a positive predictive
value of 75%, and a negative predictive value of 76%, AUC: 0.76, %95 CI: 0.64-0.88
(p<0.001) (Figure). VN was also able to predict MACE independent of other prog-
nostic markers like age, hs-CRP, pro-BNP, TIMI, GRACE, and LVEF in multivariate
regression analysis (p¼0.001).
Conclusıon: VN levels on admission predict in-hospital and medium-term MACE in
patients with ACS independent of conventional risk predictors. VN may have a utility
as a prognostic marker in patients with ACS.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
